vs
Astrana Health, Inc.(ASTH)与格罗方德(GFS)财务数据对比。点击上方公司名可切换其他公司
格罗方德的季度营收约是Astrana Health, Inc.的1.8倍($1.7B vs $950.5M),格罗方德净利率更高(14.8% vs 0.7%,领先14.1%),Astrana Health, Inc.同比增速更快(42.9% vs -2.9%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs -4.3%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
格罗方德是跨国半导体代工及设计企业,注册地为开曼群岛,总部位于美国纽约州马耳他。公司2009年3月由AMD制造业务分拆成立,2021年10月完成首次公开募股,阿联酋主权财富基金穆巴达拉投资公司目前仍持有其82%的多数股权。
ASTH vs GFS — 直观对比
营收规模更大
GFS
是对方的1.8倍
$950.5M
营收增速更快
ASTH
高出45.8%
-2.9%
净利率更高
GFS
高出14.1%
0.7%
两年增速更快
ASTH
近两年复合增速
-4.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $1.7B |
| 净利润 | $6.6M | $249.0M |
| 毛利率 | — | 24.8% |
| 营业利润率 | 1.9% | 11.6% |
| 净利率 | 0.7% | 14.8% |
| 营收同比 | 42.9% | -2.9% |
| 净利润同比 | 184.4% | 39.9% |
| 每股收益(稀释后) | $0.12 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
GFS
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $1.7B | ||
| Q2 25 | $654.8M | $1.7B | ||
| Q1 25 | $620.4M | $1.6B | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $1.7B | ||
| Q2 24 | $486.3M | $1.6B | ||
| Q1 24 | $404.4M | $1.5B |
净利润
ASTH
GFS
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $249.0M | ||
| Q2 25 | $9.4M | $228.0M | ||
| Q1 25 | $6.7M | $211.0M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $178.0M | ||
| Q2 24 | $19.2M | $155.0M | ||
| Q1 24 | $14.8M | $134.0M |
毛利率
ASTH
GFS
| Q4 25 | — | — | ||
| Q3 25 | — | 24.8% | ||
| Q2 25 | — | 24.2% | ||
| Q1 25 | — | 22.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.8% | ||
| Q2 24 | — | 24.2% | ||
| Q1 24 | — | 25.4% |
营业利润率
ASTH
GFS
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 11.6% | ||
| Q2 25 | 3.1% | 11.6% | ||
| Q1 25 | 3.3% | 9.5% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | 10.6% | ||
| Q2 24 | 6.2% | 9.5% | ||
| Q1 24 | 7.5% | 9.5% |
净利率
ASTH
GFS
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 14.8% | ||
| Q2 25 | 1.4% | 13.5% | ||
| Q1 25 | 1.1% | 13.3% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 10.2% | ||
| Q2 24 | 3.9% | 9.5% | ||
| Q1 24 | 3.7% | 8.7% |
每股收益(稀释后)
ASTH
GFS
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.44 | ||
| Q2 25 | $0.19 | $0.41 | ||
| Q1 25 | $0.14 | $0.38 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | $0.32 | ||
| Q2 24 | $0.40 | $0.28 | ||
| Q1 24 | $0.31 | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $2.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $11.8B |
| 总资产 | $2.2B | $16.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
GFS
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $2.0B | ||
| Q2 25 | $342.1M | $1.8B | ||
| Q1 25 | $260.9M | $1.6B | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | $2.3B | ||
| Q2 24 | $327.7M | $2.2B | ||
| Q1 24 | $337.3M | $2.2B |
股东权益
ASTH
GFS
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $11.8B | ||
| Q2 25 | $765.5M | $11.5B | ||
| Q1 25 | $745.4M | $11.1B | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $11.6B | ||
| Q2 24 | $678.9M | $11.3B | ||
| Q1 24 | $653.5M | $11.3B |
总资产
ASTH
GFS
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $16.7B | ||
| Q2 25 | $1.4B | $16.8B | ||
| Q1 25 | $1.3B | $16.5B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | $18.1B | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $595.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 2.39× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势,按日历期对齐
经营现金流
ASTH
GFS
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $595.0M | ||
| Q2 25 | $90.9M | $431.0M | ||
| Q1 25 | $16.6M | $331.0M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $375.0M | ||
| Q2 24 | $23.2M | $402.0M | ||
| Q1 24 | $6.0M | $488.0M |
自由现金流
ASTH
GFS
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率
ASTH
GFS
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度
ASTH
GFS
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率
ASTH
GFS
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 2.39× | ||
| Q2 25 | 9.65× | 1.89× | ||
| Q1 25 | 2.48× | 1.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 2.11× | ||
| Q2 24 | 1.21× | 2.59× | ||
| Q1 24 | 0.40× | 3.64× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
GFS
| Smart Mobile Devices | $752.0M | 45% |
| Automotive | $306.0M | 18% |
| Home And Industrial Io T | $258.0M | 15% |
| Goods Or Services Transferred Over Time | $198.0M | 12% |
| Communications Infrastructure Datacenter | $175.0M | 10% |